-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tepotinib Hydrochloride in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tepotinib Hydrochloride in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tepotinib Hydrochloride in Solid Tumor Drug Details: Tepotinib hydrochloride (Tepmetko) is anti...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tepotinib Hydrochloride in Gastroesophageal (GE) Junction Carcinomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tepotinib Hydrochloride in Gastroesophageal (GE) Junction Carcinomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tepotinib Hydrochloride in Gastroesophageal (GE) Junction Carcinomas Drug Details: Tepotinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gumarontinib in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gumarontinib in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Gumarontinib in Non-Small Cell Lung CancerDrug Details:Glumetinib (Haiyitan) is an anti...
-
Company Profile
Cargotec Oyj – Company Profile
Cargotec Oyj (Cargotec) is a provider of cargo and load handling systems and services. Its portfolio of services includes on-road load handling solutions, marine cargo flow solutions and offshore solutions, and heavy industrial material handling, container handling equipment and related solutions. The company’s products include loader cranes, tail lifts, forklifts, yard cranes, straddle carriers, reach stackers, and load handling and mooring solutions. It also provides terminal tractors, log lift forestry cranes, hook lifts, skip loaders, forestry and recycling cranes, truck-mounted...
Add to Basket -
Company Profile
Carter’s Inc – Company Profile
Carter's Inc (Carter’s) designs and markets children's apparel, accessories, and gift items. The company's offers product for baby’s, toddler, and kids. Its portfolio comprises a range of children and baby products such as bodysuits, tops and t-shirts, dresses, multi-piece sets, , play clothes, and sleepwear. It sells products online through its e-commerce platforms includingwww.carters.com, www.oshkoshbgosh.com, www.oshkosh.com, www.skiphop.com, and mobile applications. The company also sells through department stores, national chain stores, and specialty stores domestically and internationally. . Carter’s markets products...
Add to Basket -
Company Profile
Com2uS Holdings Corp – Company Profile
Com2uS Holdings Corp (Com2uS), formerly Gamevil Inc, is a gaming company that developed and published mobile games. The company game portfolio includes soccer superstars, baseball superstars, zenonia, nomzero, skipping stone and air penguin. Com2uS mobile games are applied to iPhone, iPod Touch, iPad, Android phones, Nintendo DSiWare, play station portable (PSP) devices and also Windows phones. It distributes its product under GAMEVIL, Baseball Superstars and ZENONIA registered trademarks. The company operates in the US and South Korea. Com2uS is headquartered...
Add to Basket -
Company Profile
Astellas Gene Therapies – Company Profile
Astellas Gene Therapies (Astellas Gene) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company’s major pipeline products include AT132, AT845, AT466, AT702, AT751 and AT753. It's products are used for the treatment of X-linked myotubular myopathy, pompe disease, muscular dystrophy in children and neuromuscular disease, severe respiratory insufficiency, weakness and hypotonia. The company is currently exploring three gene therapy modalities such as gene replacement, exon skipping gene therapy, and...
Add to Basket -
Product Insights
Net Present Value Model: Exondys 51
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Exondys 51 Drug Details Eteplirsen (Exondys...
-
Product Insights
Net Present Value Model: Tepmetko
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Tepmetko Drug Details Tepotinib hydrochloride (Tepmetko)...
-
Product Insights
Net Present Value Model: NS-089
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model NS-089 Drug Details NS-089 is under...